Structural insights into the human D1 and D2 dopamine receptor signaling complexes-Reference-Cited by-同舟云学术

Structural insights into the human D1 and D2 dopamine receptor signaling complexes

Published:2021-02 Issue:4 Volume:184 Page:931-942.e18
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Zhuang Youwen,Xu Peiyu^ORCID,Mao Chunyou,Wang Lei^ORCID,Krumm Brian,Zhou X. Edward,Huang Sijie,Liu Heng,Cheng Xi^ORCID,Huang Xi-Ping,Shen Dan-Dan,Xu Tinghai,Liu Yong-Feng,Wang Yue,Guo Jia,Jiang Yi,Jiang Hualiang,Melcher Karsten^ORCID,Roth Bryan L.,Zhang Yan,Zhang Cheng,Xu H. Eric

Funder

Science and Technology Commission of Shanghai Municipality

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference61 articles.

1. Prefrontal dopamine D1 receptors and working memory in schizophrenia;Abi-Dargham;J. Neurosci.,2002

2. PHENIX: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr. D Biol. Crystallogr.,2010

3. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy;Andersen;Eur. J. Pharmacol.,1990

4. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors;Ballesteros,1995

5. The physiology, signaling, and pharmacology of dopamine receptors;Beaulieu;Pharmacol. Rev.,2011

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of the molecular, cellular, and behavioral changes caused by exposure to a saline-alkali environment in the Chinese mitten crab, Eriocheir sinensis;Environmental Research;2024-12

2. Dopamine-modified hyaluronic acid (DA-HA) as a novel dopamine-mimetics with minimal autoxidation and cytotoxicity;Redox Biology;2024-10

3. Progress on the development of Class A GPCR‐biased ligands;British Journal of Pharmacology;2024-09-11

4. A bitopic agonist bound to the dopamine 3 receptor reveals a selectivity site;Nature Communications;2024-09-05

5. Using the sympathetic system, beta blockers and alpha-2 agonists, to address acute respiratory distress syndrome;International Immunopharmacology;2024-09